Gene: NRXN1

9378
Hs.22998|PTHSL2|SCZD17
neurexin 1
protein-coding
2p16.3
Ensembl:ENSG00000179915 MIM:600565 Vega:OTTHUMG00000129263 UniprotKB:P58400
NG_011878.1
PubMed|SNP Mapped
7   ANCO-SNPs
ND|AD
9   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.865e-1 (AD)  5.666e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs10490162chr2:51020519 (GRCh38.p7)T>Cnicotine dependenceSNV(Single Nucleotide Variation)
rs13382584chr2:51020156 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)
rs12467557chr2:51015132 (GRCh38.p7)A>Gnicotine dependenceSNV(Single Nucleotide Variation)
rs12623467chr2:50997951 (GRCh38.p7)C>Tnicotine dependenceSNV(Single Nucleotide Variation)
rs2193225chr2:50852344 (GRCh38.p7)T>Cnicotine dependenceSNV(Single Nucleotide Variation)
rs6721498chr2:50485874 (GRCh38.p7)G>Anicotine dependenceSNV(Single Nucleotide Variation)
rs11681792chr2:49957256 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PPM1L0.968
CHL10.961
MAPK100.959
PCDH70.959
GRIA20.957
FAM217B0.957
FAM155A0.954
AMIGO10.953
NRG30.952
PLCB10.951

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CSAG1-0.552
TFPI2-0.552
RAI14-0.536
CNN2-0.512
CMTM3-0.494
PGF-0.492
SGMS2-0.49
HEY2-0.489
OR4F5-0.489
WWTR1-0.487

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB11093Calcium CitrateSmall Molecule813-94-5ApprovedTarget
DB11348Calcium PhosphateSmall Molecule10103-46-5ApprovedTarget
ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in increased expression of NRXN1 mRNA"26377693
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NRXN1 mRNA"27291303
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of NRXN1 mRNA"19114083
C0235142,6-dinitrotoluene"2,6-dinitrotoluene results in decreased expression of NRXN1 mRNA"20406850
C0303702-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone"2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone results in decreased expression of NRXN1 mRNA"20206263
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane affects the expression of NRXN1 mRNA"18648102
C0095054,4'-diaminodiphenylmethane"4,4'-diaminodiphenylmethane results in increased expression of NRXN1 mRNA"18648102
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRXN1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRXN1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRXN1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRXN1 mRNA"27188386
C496492abrineabrine results in decreased expression of NRXN1 mRNA22595364
D000082AcetaminophenAcetaminophen affects the expression of NRXN1 mRNA17562736
D000082AcetaminophenAcetaminophen affects the expression of NRXN1 mRNA25607892
D000082Acetaminophen[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA25607892
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of NRXN1 gene27153756
D000448AldicarbNRXN1 protein affects the reaction [NLG-1 results in increased susceptibility to Aldicarb]23638761
D000448AldicarbNRXN1 protein affects the reaction [NRX-1 results in decreased susceptibility to Aldicarb]23638761
C020763alpha-latrotoxinalpha-latrotoxin binds to NRXN1 protein7592578
C020763alpha-latrotoxinCalcium promotes the reaction [alpha-latrotoxin binds to NRXN1 protein]7592578
C020763alpha-latrotoxinEgtazic Acid inhibits the reaction [Calcium promotes the reaction [alpha-latrotoxin binds to NRXN1 protein]]7592578
C020763alpha-latrotoxinCalcium affects the reaction [alpha-latrotoxin binds to NRXN1 protein]9430716
C020763alpha-latrotoxinNRXN1 protein results in increased susceptibility to alpha-latrotoxin9430716
C020763alpha-latrotoxinalpha-latrotoxin binds to NRXN1 protein9430716
D000535Aluminum[APP protein modified form binds to Aluminum] which results in increased expression of NRXN1 mRNA21298039
D000643Ammonium ChlorideAmmonium Chloride affects the expression of NRXN1 mRNA16483693
D000726Androgen Antagonists[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA25607892
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of NRXN1 mRNA24449571
D001151ArsenicArsenic affects the methylation of NRXN1 gene25304211
D001205Ascorbic AcidAscorbic Acid results in decreased expression of NRXN1 mRNA15372504
C547126AZM551248AZM551248 results in decreased expression of NRXN1 mRNA22323515
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of NRXN1 mRNA22316170
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of NRXN1 mRNA21569818
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of NRXN1 mRNA21839799
C006780bisphenol Abisphenol A results in increased expression of NRXN1 mRNA25594700
C006780bisphenol A[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA25607892
C006780bisphenol A[bisphenol A co-treated with Genistein] results in increased methylation of NRXN1 gene28505145
C006780bisphenol Abisphenol A results in decreased expression of NRXN1 mRNA25181051
C006780bisphenol Abisphenol A results in increased expression of NRXN1 mRNA29097150
C006780bisphenol Abisphenol A results in increased methylation of NRXN1 gene28505145
C038599black widow spider venomblack widow spider venom binds to NRXN1 protein7592578
C038599black widow spider venomCalcium promotes the reaction [black widow spider venom binds to NRXN1 protein]7592578
C038599black widow spider venomEgtazic Acid inhibits the reaction [Calcium promotes the reaction [black widow spider venom binds to NRXN1 protein]]7592578
C038599black widow spider venomCalcium affects the reaction [black widow spider venom binds to NRXN1 protein]9430716
C038599black widow spider venomNRXN1 protein results in increased susceptibility to black widow spider venom9430716
C038599black widow spider venomblack widow spider venom binds to NRXN1 protein9430716
C038091butylparaben[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA25607892
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of NRXN1 protein21136600
D019256Cadmium ChlorideCadmium Chloride results in decreased methylation of NRXN1 promoter22457795
D002118CalciumCalcium promotes the reaction [alpha-latrotoxin binds to NRXN1 protein]7592578
D002118CalciumCalcium promotes the reaction [black widow spider venom binds to NRXN1 protein]7592578
D002118CalciumEgtazic Acid inhibits the reaction [Calcium promotes the reaction [alpha-latrotoxin binds to NRXN1 protein]]7592578
D002118CalciumEgtazic Acid inhibits the reaction [Calcium promotes the reaction [black widow spider venom binds to NRXN1 protein]]7592578
D002118CalciumCalcium affects the reaction [alpha-latrotoxin binds to NRXN1 protein]9430716
D002118CalciumCalcium affects the reaction [black widow spider venom binds to NRXN1 protein]9430716
D002251Carbon TetrachlorideCarbon Tetrachloride affects the expression of NRXN1 mRNA17484886
D002713Chlorine[Ozone co-treated with Chlorine] affects the expression of NRXN1 mRNA18636392
D002737ChloropreneChloroprene results in increased expression of NRXN1 mRNA23125180
D003471CuprizoneCuprizone results in decreased expression of NRXN1 mRNA26577399
D013759DronabinolDronabinol results in decreased expression of NRXN1 mRNA16616335
D003993Dibutyl Phthalate[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
D003633Dichlorodiphenyl Dichloroethylene[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
D004041Dietary FatsDietary Fats results in decreased expression of NRXN1 mRNA25016146
D004051Diethylhexyl Phthalate[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NRXN1 mRNA"22485181
D004533Egtazic AcidEgtazic Acid inhibits the reaction [Calcium promotes the reaction [alpha-latrotoxin binds to NRXN1 protein]]7592578
D004533Egtazic AcidEgtazic Acid inhibits the reaction [Calcium promotes the reaction [black widow spider venom binds to NRXN1 protein]]7592578
C038939enzacamene[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA25607892
C109476epoxiconazole[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
D004997Ethinyl Estradiol[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRXN1 mRNA17942748
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of NRXN1 mRNA29097150
C039281furanfuran results in decreased expression of NRXN1 mRNA25539665
D019833Genistein[bisphenol A co-treated with Genistein] results in increased methylation of NRXN1 gene28505145
D006820Hyaluronic AcidHyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRXN1 protein]23178681
D006861Hydrogen PeroxideHyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRXN1 protein]23178681
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of NRXN1 protein23178681
D007854LeadLead affects the splicing of NRXN1 mRNA28903495
C029433lead tetraacetatelead tetraacetate results in decreased expression of NRXN1 mRNA20865013
D008044Linuron[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
D008727MethotrexateMethotrexate affects the expression of NRXN1 mRNA18502557
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of NRXN1 mRNA28001369
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NRXN1 mRNA"20188158
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of NRXN1 mRNA"25554681|2562005
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of NRXN1 mRNA"25554681
D009532NickelNickel results in decreased expression of NRXN1 mRNA24768652|2558310
C118580octylmethoxycinnamate[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA25607892
C009618O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate"O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of NRXN1 mRNA"21673326
C009618O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate"PON1 protein affects the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased expression of NRXN1 mRNA]"21673326
D009966OrphenadrineOrphenadrine affects the expression of NRXN1 mRNA23665939
D010126Ozone[Ozone co-treated with Chlorine] affects the expression of NRXN1 mRNA18636392
D052638Particulate MatterParticulate Matter affects the methylation of NRXN1 promoter28153600
D052638Particulate MatterParticulate Matter results in decreased expression of NRXN1 mRNA28153600
D010433PentylenetetrazoleNRXN1 protein affects the reaction [NLG-1 results in decreased susceptibility to Pentylenetetrazole]23638761
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRXN1 mRNA"27188386
C006253pirinixic acidpirinixic acid results in decreased expression of NRXN1 mRNA23811191
D011192Potassium DichromatePotassium Dichromate results in increased expression of NRXN1 mRNA23608068
C045362prochloraz[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
C035988procymidone[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
C043680ptaquilosideptaquiloside results in decreased expression of NRXN1 mRNA23274088
C017947sodium arsenitesodium arsenite affects the methylation of NRXN1 gene28589171
D053260SootSoot results in decreased expression of NRXN1 mRNA26551751
D013739TestosteroneTestosterone affects the expression of NRXN1 mRNA20403060
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRXN1 mRNA17942748
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of NRXN1 mRNA11752688
D014212TretinoinTretinoin results in increased expression of NRXN1 mRNA21934132
C012589trichostatin Atrichostatin A results in increased expression of NRXN1 mRNA24935251
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of NRXN1 mRNA19042947
C057693troglitazonetroglitazone results in increased expression of NRXN1 mRNA28973697
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRXN1 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of NRXN1 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of NRXN1 mRNA23179753|2438349
D001335Vehicle EmissionsVehicle Emissions affects the methylation of NRXN1 gene25560391
C025643vinclozolin[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of NRXN1 mRNA25607892
C025643vinclozolinvinclozolin affects the expression of NRXN1 mRNA19015723

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005246calcium channel regulator activity-ISS-  
GO:0005509calcium ion binding-ISS-  
GO:0005515protein binding-IPI11152476  
GO:0033130acetylcholine receptor binding-ISS-  
GO:0038023signaling receptor activity-TAS1621094  
GO:0050839cell adhesion molecule binding-ISS-  
GO:0097109neuroligin family protein binding-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0007158neuron cell-cell adhesion-TAS18923512  
GO:0007165signal transduction-IEA-  
GO:0007268chemical synaptic transmission-ISS-  
GO:0007269neurotransmitter secretion-ISS-  
GO:0007411axon guidance-TAS1621094  
GO:0007416synapse assembly-ISS-  
GO:0007612learning-IMP19896112  
GO:0030534adult behavior-IMP19896112  
GO:0035176social behavior-IMP18057082  19896112  
GO:0042297vocal learning-IMP19896112  
GO:0050885neuromuscular process controlling balanceNOTIMP19896112  
GO:0050885neuromuscular process controlling balance-ISS19822762  
GO:0051965positive regulation of synapse assembly-ISS-  
GO:0051968positive regulation of synaptic transmission, glutamatergic-ISS19822762  
GO:0060134prepulse inhibition-IEA-  
GO:0061178regulation of insulin secretion involved in cellular response to glucose stimulus-IEA-  
GO:0071625vocalization behavior-IMP18057082  19896112  
GO:0090129positive regulation of synapse maturation-ISS-  
GO:0097104postsynaptic membrane assembly-ISS-  
GO:0097116gephyrin clustering involved in postsynaptic density assembly-ISS-  
GO:0097118neuroligin clustering involved in postsynaptic membrane assembly-ISS-  
GO:0097119postsynaptic density protein 95 clustering-ISS-  
GO:0099560synaptic membrane adhesion-IEA-  
GO:2000463positive regulation of excitatory postsynaptic potential-ISS19822762  
GO:2000821regulation of grooming behavior-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005730nucleolus-IDA-  
GO:0005783endoplasmic reticulum-ISS-  
GO:0005886plasma membrane-IC21424692  
GO:0005886plasma membrane-IDA-  
GO:0005886plasma membrane-ISS-  
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-TAS1621094  
GO:0009986cell surface-IDA21424692  
GO:0030054cell junction-IEA-  
GO:0031965nuclear membrane-ISS-  
GO:0031982vesicle-ISS-  
GO:0032991protein-containing complex-IEA-  
GO:0042734presynaptic membrane-ISS-  
GO:0043025neuronal cell body-ISS-  
KEGG ID KEGG Term
hsa04514Cell adhesion molecules (CAMs)
Reactome ID Reactome Term Evidence
R-HSA-112316Neuronal SystemIEA
R-HSA-112316Neuronal SystemTAS
R-HSA-1474244Extracellular matrix organizationIEA
R-HSA-3000171Non-integrin membrane-ECM interactionsIEA
R-HSA-6794361Neurexins and neuroliginsIEA
R-HSA-6794361Neurexins and neuroliginsTAS
R-HSA-6794362Protein-protein interactions at synapsesIEA
R-HSA-6794362Protein-protein interactions at synapsesTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
19658047Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study. (2009)Novak GWorld J Biol Psychiatry
27355804SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways. (2016 Jul)Perez-Rubio GPharmacogenomics
20468056Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. (2010 Jun 5)Ching MSAm J Med Genet B Neuropsychiatr Genet
27613936High Prevalence of Smoking in the Roma Population Seems to Have No Genetic Background. (2016 Dec)Fiatal SNicotine Tob Res
21477380A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population. (2011 Apr 11)Yue WBehav Brain Funct
20162629Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay. (2010 Jul)Wisniowiecka-Kowalnik BAm J Med Genet B Neuropsychiatr Genet
20414139Association between neurexin 1 (NRXN1) polymorphisms and the smoking behavior of elderly Japanese. (2010 Jun)Sato NPsychiatr Genet
18270208Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. (2008 Jun 1)Nussbaum JHum Mol Genet
16451640A genome-wide scanning and fine mapping study of COGA data. (2005 Dec 30)Yang HCBMC Genet